Life sciences talent consultancy supplying clinical and research specialists
Hlx Life Sciences is a London-based talent consultancy placing specialists into pharma, biotech, CRO, CDMO and medtech clients. Its posted roles skew heavily toward senior research and healthcare profiles, including Medical Director and Clinical Development leadership, with pain points centered on ICH-GCP compliance and CRO oversight, so most openings appear to be client clinical-trial mandates rather than internal headcount. Hiring is accelerating across Japan, Australia, the US and Europe.
Notable leadership hires: Medical Director, Clinical Development, Medical Director
Hlx Life Sciences is a privately held talent services firm founded in 2024, headquartered in London with an office in Basel. It serves life science organisations across pharmaceuticals, biotechnology, TechBio, CROs, CDMOs, health technology and medical devices. Its offering includes an embedded FTE resourcing model drawn from a virtual bench and an outsourced project-hiring service that represents client companies in the market. The firm employs 11–50 people and recruits across the United Kingdom, United States, Germany, Bulgaria, Japan and Australia.
Hlx Life Sciences is a London- and Basel-based talent consultancy providing embedded FTE resourcing and outsourced project hiring to pharma, biotech, CRO, CDMO, health tech and medical device companies.
Hlx Life Sciences recruits in the United Kingdom, United States, Germany, Bulgaria, Japan and Australia, with current activity pointing to expansion into Japan and wider APAC markets.
Openings lean toward senior research and healthcare specialists, including Medical Director and Clinical Development leadership, alongside smaller needs in HR, legal, logistics and recruitment.
Other companies in the same industry, closest in size
Hlx Life Sciences's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.